Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001974078-23-000135
Filing Date
2023-09-01
Accepted
2023-09-01 12:20:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2966
  Complete submission text file 0001974078-23-000135.txt   4499
Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Subject) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-33038 | Film No.: 231231551
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZIOPHARM ONCOLOGY, INC. ONE FIRST AVENUE, PARRIS BLDG 34 BOSTON MA 02129
Business Address
Boyle Kevin S. Sr. (Reporting) CIK: 0001880600 (see all company filings)

Type: 144